721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III

Trial in progress Safety and feasibility of a venetoclax augmented treosulfan based reduced intensity conditioning before allogeneic stem cell transplantation in AML MDS AML and higher risk MDS VeStAL

Safety and feasibility of outpatient myeloablative total marrow and lymphoid Irradiation–based allogeneic transplantation in adults with high risk acute lymphoblastic leukemia

Earlier detection of transplant associated thrombotic microangiopathy using harmonization criteria A real world comparative evaluation with conventional criteria

Safety of myeloablative total marrow and lymphoid irradiation versus chemotherapy based conditioning in adults with high risk acute lymphoblastic leukemia in a limited resources setting

Treosulfan based vs busulfan based conditioning for hematopoietic stem cell transplantation A systematic review and meta analysis

Haploidentical hematopoietic stem cell transplantation using low dose alemtuzumab is effective for standard risk hematological malignancies

The ABC 14 regimen Azacitidine Venetoclax and Chidamide as a bridge to allogeneic hematopoietic stem cell transplantation for Acute Myeloid Leukemia A single center experience

Study on five year continuous improvement path for perianal infection prevention and control in hematopoietic stem cell transplantation Patients—Achieving zero infection through data driven and optimized nursing schemes

Prophylactic rituximab administered on day 1 during conditioning significantly reduces early EBV reactivation in pediatric allogeneic HSCT Real world evidence from a propensity matched cohort of 834 patients

Optimizing outcomes and accessibility of matched sibling donor transplantation for severe hemoglobinopathies in low resource settings

Effect of pre allogeneic HCT splenic irradiation on post transplant engraftment and outcomes in patients with myelofibrosis A single center experience

A single centre comparison of thiotepa treosulfan versus thiotepa busulfan based conditioning regimens in adults with haematological malignancies undergoing allogeneic haematopoietic stem cell transplant

Outcomes of HLA matched unrelated versus haploidentical hematopoietic cell transplantation in acute leukemia A multicenter observational study in Brazil facilitated by the CIBMTR

Impact of thiotepa dose in haploidentical allogeneic stem cell transplantation with thiotepa busulfan fludarabine conditioning for Acute Myeloid Leukemia in remission A retrospective analysis of the EBMT acute leukemia working party

Impact of fludarabine exposure on overall survival in patients receiving fludarabine cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

High dose cryopreserved bone marrow from deceased donors may reduce relapse in HLA mismatched allogeneic transplantation Day 180 post transplant HOPE update

Thiotepa and busulfan combined with cyclophosphamide conditioning regimen plus maintenance therapy improved the disease free survival of patients with relapsed refractory haematologic malignancies after undergoing allogeneic transplantation

Sequential therapy with fitcy preparative regimen for patients above the age of 70 years with active AML – a single center retrospective analysis

Romiplostim N01 enhances platelet engraftment in ASCT using non cryopreserved pbscs for plasma cell neoplasms A single center phase II study in China

Tailoring TBI for vulnerable patients 8 gy TBI shows comparable outcomes to 12 gy TBI in adult ALL allo HSCT

Clinically significant cytomegalovirus infection csCMVi after matched related donor allogeneic HSCT using post transplant cyclophosphamide A systematic review and meta analysis

Impact of dementia on in hospital outcomes in hematopoietic stem cell transplant HSCT recipients A nationwide cohort study